Furthermore, we showed an association of semaphorin levels with COVID-19 severity; SEMA3F and SEMA7A were higher in critical COVID-19, while SEMA3A and SEMA3C negatively correlated with COVID-19 severity and were lower in the critical group. Here, SEMA3F is linked to COVID-19.